China-Biotics Diversifies Product Mix, Begins Work On New Bulk Plant
This article was originally published in PharmAsia News
Executive Summary
Probiotics developer and manufacturer China-Biotics credits diversifying its product mix with driving 36.2 percent growth in net sales to $11.9 million for its fiscal 2008 third quarter, the firm said Feb. 13